Efficacy of Surface Electrical Stimulation for Urge Urinary Incontinence in Women

Last updated: December 9, 2024
Sponsor: Elidah, Inc.
Overall Status: Completed

Phase

N/A

Condition

Urinary Incontinence

Overactive Bladder

Enuresis

Treatment

ELITONE UUI

Clinical Study ID

NCT04752709
TR-1155
  • Ages 21-80
  • Female

Study Summary

The purpose of this research is to evaluate the effectiveness of the ELITONE-UUI electrical muscle stimulation device on treating urge incontinence. The aim of the device is to stimulate the pelvic floor muscles and surrounding structures to improve urinary incontinence.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Predominant urge urinary incontinence as determined by responses to a series ofthree standard questions from the King's Health Questionnaire; specifically:

  • An affirmative response to "Is it very difficult to control when you have astrong urge to urinate?",

  • An affirmative or negative response to "Do you lose urine with physicalactivities such as coughing, sneezing, running?",

  • And, if an affirmative response to the second question, an affirmative responseto "Are more of your incontinence episodes due to a strong urge to urinate thanto abdominal pressure such as sneezing?"

  • Mild-moderate incontinence symptoms as determined by self-reported typical number ofaccidents of 1 or more per 24 hours. Symptom severity is later verified with datafrom the Daily Log (See 5.4)

Exclusion

Exclusion Criteria:

  • Less than 1 incontinence accident (leak) per day*

  • Severe incontinence as determined by self-reported >5 accidents per day

  • Currently pregnant, may be pregnant, attempting to become pregnant, or deliverywithin previous 6 weeks

  • Vaginal or pelvic surgery within previous 6 months

  • Severe Obesity as defined by BMI >= 35

  • Change in incontinence medication type or dosing within the last 3 months.

  • History or symptoms of urinary retention, extra-urethral incontinence, overflowincontinence

  • Pelvic pain/painful bladder syndrome

  • Active urinary tract infection (UTI) or history of recurrent UTIs (more than threein a year), or recurrent vaginitis (bacterial/fungal)

  • Tissues protruding outside the vagina at rest

  • Presence of incontinence-associated dermatitis or other perineal skin disorders orlesions,

  • Complete denervation of the pelvic floor

  • Conductive inter-uterine devise (IUD/Coil) or metal implants in the abdominal orpelvic area, including the hip and lumbar spine,

  • Chronic coughing

  • Previous use of Interstim device or Botox for UI

  • Implanted cardiac device, untreated cardiac arrhythmia or suffer from other heartproblems.

  • Cancer, epilepsy or cognitive dysfunction

  • Underlying neurologic/neuromuscular disorder

  • Impaired decision making, suicidal thoughts, or drug/alcohol dependence

  • Lacks capacity to consent for themselves.

Study Design

Total Participants: 82
Treatment Group(s): 1
Primary Treatment: ELITONE UUI
Phase:
Study Start date:
November 19, 2020
Estimated Completion Date:
September 30, 2021

Study Description

The purpose of this research is to evaluate the effectiveness of the ELITONE-UUI electrical muscle stimulation device on treating urge incontinence in women. The aim of the device is to stimulate the pelvic floor muscles and surrounding structures to improve urinary incontinence. This is a randomized prospective controlled study of two active groups with a stimulation frequency difference between the groups.

Connect with a study center

  • Elidah

    Monroe, Connecticut 06468
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.